» Articles » PMID: 35108108

Glycine Receptor Subunit-β-deficiency in a Mouse Model of Spasticity Results in Attenuated Physical Performance, Growth, and Muscle Strength

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Spasticity is the most common neurological disorder associated with increased muscle contraction causing impaired movement and gait. The aim of this study was to characterize the physical performance, skeletal muscle function, and phenotype of mice with a hereditary spastic mutation (B6.Cg-Glrb/J). Motor function, gait, and physical activity of juvenile and adult spastic mice and the morphological, histological, and mechanical characteristics of their soleus and gastrocnemius medialis muscles were compared with those of their wild-type (WT) littermates. Spastic mice showed attenuated growth, impaired motor function, and low physical activity. Gait of spastic mice was characterized by a typical hopping pattern. Spastic mice showed lower muscle forces, which were related to the smaller physiological cross-sectional area of spastic muscles. The muscle-tendon complex length-force relationship of adult gastrocnemius medialis was shifted toward shorter lengths, which was explained by attenuated longitudinal tibia growth. Spastic gastrocnemius medialis was more fatigue resistant than WT gastrocnemius medialis. This was largely explained by a higher mitochondrial content in muscle fibers and relatively higher percentage of slow-type muscle fibers. Muscles of juvenile spastic mice showed similar differences compared with WT juvenile mice, but these were less pronounced than between adult mice. This study shows that in spastic mice, disturbed motor function and gait is likely to be the result of hyperactivity of skeletal muscle and impaired skeletal muscle growth, which progress with age.

Citing Articles

Muscle type-specific effects of bilateral abobotulinumtoxinA injection on muscle growth and contractile function in spastic mice.

Rivares C, Vignaud A, Noort W, Baan G, Koopmans B, Loos M FASEB J. 2024; 38(22):e70141.

PMID: 39560920 PMC: 11636637. DOI: 10.1096/fj.202302258R.


Inhibitory Synaptic Influences on Developmental Motor Disorders.

Fogarty M Int J Mol Sci. 2023; 24(8).

PMID: 37108127 PMC: 10138861. DOI: 10.3390/ijms24086962.

References
1.
Kruse A, Rivares C, Weide G, Tilp M, Jaspers R . Stimuli for Adaptations in Muscle Length and the Length Range of Active Force Exertion-A Narrative Review. Front Physiol. 2021; 12:742034. PMC: 8531727. DOI: 10.3389/fphys.2021.742034. View

2.
Van der Meer S, Jaspers R, Jones D, Degens H . The time course of myonuclear accretion during hypertrophy in young adult and older rat plantaris muscle. Ann Anat. 2010; 193(1):56-63. DOI: 10.1016/j.aanat.2010.08.004. View

3.
White R, Bierinx A, Gnocchi V, Zammit P . Dynamics of muscle fibre growth during postnatal mouse development. BMC Dev Biol. 2010; 10:21. PMC: 2836990. DOI: 10.1186/1471-213X-10-21. View

4.
Bottos M, Benedetti M, Salucci P, Gasparroni V, Giannini S . Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment. Dev Med Child Neurol. 2003; 45(11):758-62. DOI: 10.1017/s0012162203001403. View

5.
Huijing P . Muscle, the motor of movement: properties in function, experiment and modelling. J Electromyogr Kinesiol. 1998; 8(2):61-77. DOI: 10.1016/s1050-6411(97)00023-0. View